NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Travilah Consulting Group

Travilah Consulting Group

Palo Alto, Californiatcg-x.com

Overview

TCG Crossover, known as TCGX, is a healthcare and life sciences-focused investment firm that invests in both private and public companies. The firm focuses on innovative drug discovery companies and leverages a network of scientific advisors and operational executives to support its portfolio. TCGX employs a long-term, patient capital strategy through a closed-end fund structure. The firm was founded in 2021 by Dr. Chen Yu and has offices in Palo Alto and New York City.

Portfolio Companies

4

Website

tcg-x.com

Investments

CompanyDateStageLead
Mineralys TherapeuticsFeb 2024Private PlacementCo-investor
Cargo TherapeuticsMar 2023Series A-
RayzeBioJun 2021Series C-
LianBioOct 2020Series A-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPalo Alto, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.